EAM
Exane Asset Management Portfolio holdings
AUM
$256M
1-Year Return
8.08%
This Quarter Return
-6.27%
1 Year Return
+8.08%
3 Year Return
+70.48%
5 Year Return
+81.39%
10 Year Return
–
AUM
$170M
AUM Growth
-$149M
(-47%)
Cap. Flow
-$123M
Cap. Flow
% of AUM
-72.33%
Top 10 Holdings %
Top 10 Hldgs %
68.38%
Holding
199
New
70
Increased
19
Reduced
16
Closed
92
Top Buys
| 1 |
Takeda Pharmaceutical
TAK
|
$15.7M |
| 2 |
T-Mobile US
TMUS
|
$11.4M |
| 3 |
AT&T
T
|
$11.1M |
| 4 |
Sherwin-Williams
SHW
|
$7.05M |
| 5 |
RHT
Red Hat Inc
RHT
|
$5.27M |
Top Sells
| 1 |
Qiagen
QGEN
|
$19.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
$13.9M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12M |
| 4 |
UBS Group
UBS
|
$11M |
| 5 |
Gilead Sciences
GILD
|
$10.2M |
Sector Composition
| 1 | Materials | 31.17% |
| 2 | Communication Services | 24.88% |
| 3 | Healthcare | 19.33% |
| 4 | Utilities | 7.37% |
| 5 | Technology | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Exelon
EXC
$43.7B
| $1.16M | 0.68% |
36,072
| – | – |
|
27
Ovintiv
OVV
$10.9B
| $1.16M | 0.68% |
+40,000
| New | +$1.16M |
|
|
IDTI
28
DELISTED
Integrated Device Technology I
IDTI
| $1.13M | 0.66% |
+23,350
| New | +$1.13M |
|
|
NXTM
29
DELISTED
NxStage Medical Inc.
NXTM
| $1.1M | 0.65% |
38,505
-178
| -0.5% | -$5.09K |
|
30
Axalta
AXTA
$6.71B
| $1.07M | 0.63% |
45,537
-306,822
| -87% | -$7.19M |
|
|
AGR
31
DELISTED
Avangrid, Inc.
AGR
| $1.06M | 0.62% |
21,071
+7,052
| +50% | +$353K |
|
|
DBVT
32
DBV Technologies
DBVT
$254M
| $899K | 0.53% |
14,000
+7,500
| +115% | +$482K |
|
33
Criteo
CRTO
$1.22B
| $807K | 0.47% |
+35,500
| New | +$807K |
|
34
CytomX Therapeutics
CTMX
$340M
| $755K | 0.44% |
50,000
+22,100
| +79% | +$334K |
|
|
ARRS
35
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $629K | 0.37% |
+20,590
| New | +$629K |
|
36
Thermo Fisher Scientific
TMO
$184B
| $604K | 0.35% |
2,700
-700
| -21% | -$157K |
|
37
Occidental Petroleum
OXY
$45.9B
| $478K | 0.28% |
7,782
-36
| -0.5% | -$2.21K |
|
|
FTSV
38
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $424K | 0.25% |
+27,000
| New | +$424K |
|
39
Vermilion Energy
VET
$1.16B
| $348K | 0.2% |
16,474
-13,176
| -44% | -$278K |
|
40
DaVita
DVA
$9.75B
| $296K | 0.17% |
+5,753
| New | +$296K |
|
41
Lumen
LUMN
$5.14B
| $289K | 0.17% |
+19,060
| New | +$289K |
|
|
42
UBS Group
UBS
$128B
| $264K | 0.15% |
21,199
-879,586
| -98% | -$11M |
|
43
EOG Resources
EOG
$66.4B
| $262K | 0.15% |
3,002
+2,563
| +584% | +$224K |
|
|
AHL
44
DELISTED
ASPEN Insurance Holding Limited
AHL
| $254K | 0.15% |
+6,051
| New | +$254K |
|
|
WCG
45
DELISTED
Wellcare Health Plans, Inc.
WCG
| $220K | 0.13% |
+931
| New | +$220K |
|
|
JWN
46
DELISTED
Nordstrom
JWN
| $219K | 0.13% |
+4,705
| New | +$219K |
|
47
Jacobs Solutions
J
$17.1B
| $219K | 0.13% |
+4,519
| New | +$219K |
|
|
TIF
48
DELISTED
Tiffany & Co.
TIF
| $218K | 0.13% |
+2,704
| New | +$218K |
|
49
Ralph Lauren
RL
$19.3B
| $218K | 0.13% |
+2,104
| New | +$218K |
|
50
Aptiv
APTV
$17.5B
| $218K | 0.13% |
+3,533
| New | +$218K |
|